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Fructose-1,6-bisphosphate aldolase (aldolase) is an essential
enzyme in glycolysis and gluconeogenesis. In addition to this
primary function, aldolase is also known to bind to a variety of
other proteins, a property that may allow it to perform
‘moonlighting’ roles in the cell. Although monomeric and
dimeric aldolases possess full catalytic activity, the enzyme
occurs as an unusually stable tetramer, suggesting a possible
link between the oligomeric state and these noncatalytic
cellular roles. Here, the ﬁrst high-resolution X-ray crystal
structure of rabbit muscle D128V aldolase, a dimeric form of
aldolase mimicking the clinically important D128G mutation
in humans associated with hemolytic anemia, is presented. The
structure of the dimer was determined to 1.7 A ˚ resolution with
the product DHAP bound in the active site. The turnover of
substrate to produce the product ligand demonstrates the
retention of catalytic activity by the dimeric aldolase. The
D128V mutation causes aldolase to lose intermolecular
contacts with the neighboring subunit at one of the two
interfaces of the tetramer. The tertiary structure of the dimer
does not signiﬁcantly differ from the structure of half of the
tetramer. Analytical ultracentrifugation conﬁrms the occur-
rence of the enzyme as a dimer in solution. The highly stable
structure of aldolase with an independent active site is
consistent with a model in which aldolase has evolved as a
multimeric scaffold to perform other noncatalytic functions.
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1. Introduction
Fructose-1,6-bisphosphate aldolase (aldolase; EC 4.1.2.13) is a
ubiquitously expressed glycolytic enzyme that catalyzes the
reversible cleavage of fructose 1,6-bisphosphate (Fru 1,6-P2)
to dihydroxyacetone phosphate (DHAP) and glyceraldehyde
3-phosphate (G3P) in glycolysis and the reverse reaction in
gluconeogenesis. In addition, aldolase is involved in the
metabolism of fructose, converting fructose 1-phosphate (Fru
1-P) to DHAP and glyceraldehyde (Horecker et al., 1975).
There are two classes of aldolases based on their chemical
mechanism: class I enzymes are cofactor-independent and
catalyze C—C bond cleavage via the formation of a Schiff-
base intermediate with the sugar, whereas class II enzymes
require a divalent metal ion for catalysis. The class I aldolases
of vertebrates are further subdivided into three isozymes that
have different activities and vary in their tissue distribution
(Rutter, 1964). The isoforms aldolase A (predominantly
present in muscle) and aldolase C (in brain) have higher
activity towards Fru 1,6-P2 than towards Fru 1-P. Aldolase B
(in liver) has equal turnover numbers for both Fru 1,6-P2 and
Fru 1-P, corresponding to its role in fructose metabolism in theliver (Penhoet & Rutter, 1971). The amino-acid sequences of
these isozymes are highly conserved, predominantly at the
subunit interface and the active site (Rottmann et al., 1984,
1987; Lai et al., 1974; Deng & Smith, 1999), with 81, 70 and
70% overall sequence identity between A and C, between A
and B and between B and C, respectively.
Biochemical studies supported by crystal structures have
shown that class I aldolases are invariably present as homo-
tetramers (Penhoet et al., 1967). Each subunit has an inde-
pendent active site that resides in the center of the barrel in a
( / )8-barrel fold (Sygusch et al., 1987). Although the
quaternary structure is not required for enzymatic activity
(Beernink & Tolan, 1996), the dissociation constant is
unusually low, of the order of 10
 26 M
3 for the monomer–
tetramer equilibrium (Tolan et al., 2003). This dissociation
constant is lower than those of other glycolytic enzymes and
raises the question of why aldolase has evolved to possess such
a very tight interaction at the protein–protein interfaces.
Steady-state kinetic studies of aldolase isozymes have shown
no cooperativity among the subunits, thus aldolase does not
display allosteric regulation (Penhoet & Rutter, 1971).
Perhaps linked to these ﬁndings, there is considerable
evidence that aldolase participates in nonmetabolic processes
in addition to its enzymatic role. Aldolase is involved in
binding interactions with several other proteins, but the
functional role of aldolase in these interactions has not been
fully characterized. Aldolases A and C have been found to
bind to the neuroﬁlament light-chain mRNA in neurons
(Can ˜ete-Soler et al., 2005). Aldolase A associates with the
vacuolar H
+-ATPase (Lu et al., 2001) and is thought to
mediate its assembly, expression, and activity as a proton
pump (Lu et al., 2004). Aldolase also plays a role in the control
of proteins involved in endocytosis (Lundmark & Carlsson,
2004). There are other binding partners for which no func-
tional role has been established, including  -tubulin (Volker &
Knull, 1997), heparin (Ta et al., 1999), phospholipase D (Kim
et al., 2002) and the glucose transporter GLUT4 (Kao et al.,
1999). Aldolase A has been proposed to play a structural role
in the assembly of the actin cytoskeleton in vivo owing to its
well established ability to bind F-actin (Arnold & Pette, 1968;
Arnold et al., 1971; O’Reilly & Clarke, 1993). Further studies
have shown that tetrameric aldolase can cross-link F-actin
ﬁlaments into a gel or rafts, which is consistent with a potential
role for this enzyme in the regulation of cytoskeleton structure
(Pagliaro & Taylor, 1988; Wang et al., 1996; Sukow & De-
Rosier, 1998). The ability to cross-link actin points to the
multimeric state of aldolase as a prerequisite for its ‘moon-
lighting’ functions, i.e. a single protein–protein interface can
thus provide multiple interactions.
Some of the activities of aldolase appear to link catalytic
activity to quaternary structure. Aldolase A deﬁciency is an
autosomal recessive trait and has been associated with
nonspherocytic hemolytic anemia in humans (Beutler et al.,
1973). One of the most well studied alleles, D128G (Kishi et
al., 1987), results in a thermally unstable protein. The source
of this instability has been studied further using this and other
Asp128 substitutions (Beernink & Tolan, 1994) and showed
that the varying degrees of thermolability correlated with
varying degrees of dissociation into dimers. The largest shift in
the equilibrium towards the dimer is caused by the substitu-
tion of Asp128 by Val (Beernink & Tolan, 1994). The structure
of the aldolase tetramer and the position of Asp128 are shown
in Fig. 1.
Here, using D128V aldolase, a high-resolution crystal
structure of the dimeric form was explored. The data provided
a structural basis for understanding the loss of quaternary
structure and showed that the protein was stablein the dimeric
form. Remarkably, the dimer did not differ signiﬁcantly from
the corresponding half-tetramer in native aldolases. Since the
asymmetric unit contained a single monomer, analysis of
D128V aldolase was performed via analytical ultra-
centrifugation to support the assignment of the crystallo-
graphically generated dimer as the biological unit. The
product DHAP was bound to the active site after crystal-
lization with the substrate Fru 1,6-P2, which showed that
D128V aldolase was catalytically competent. The crystal
structure of the dimer will provide a structural basis for studies
of aldolase in its role as a binding partner in cellular processes.
2. Materials and methods
2.1. Expression and purification of recombinant aldolase
D128V aldolase was puriﬁed as previously described
(Beernink & Tolan, 1994), with the exception that in the last
step of puriﬁcation the CM-Sepharose Fast Flow (GE
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Figure 1
Rabbit muscle fructose-1,6-bisphophate aldolase tetramer (Blom &
Sygusch, 1997; PDB code 1ado). Each monomer is colored separately,
with the A and B interfaces indicated by arrows as described previously
(Beernink & Tolan, 1994). The sites of the D128V substitutions are
indicated by red spheres on interface B and the C- and N-termini are
labeled for monomer A.Healthcare) column was washed with 50 mM TAPS–glycine–
KOH pH 8.3, 1 mM dithiothreitol (DTT) and D128Valdolase
was eluted with the same buffer containing 2 mM Fru 1,6-P2.
Activity was determined by following NADH oxidation at
340 nm in a coupled assay with triosephosphate isomerase and
glycerol-3-phosphate dehydrogenase (Racker, 1947). The
active fractions were concentrated and exchanged with crys-
tallization buffer comprised of 50 mM Tris–HCl pH 7.0,
50 mM NaCl, 25 mM ammonium acetate using an Ultrafree
centrifugal concentrator (Millipore) with a 10 kDa molecular-
weight cutoff membrane. The protein was >95% pure as
assessed by SDS–PAGE.
2.2. Crystallization, data collection and processing
D128V aldolase crystals were grown by the hanging-drop
vapor-diffusion method using Hampton Research Crystal
Screens I and II to screen initial crystallization conditions. The
ﬁnal optimized condition used a 1:1 ratio of protein in crys-
tallization buffer to reservoir solution (0.2 M ammonium
sulfate, 25% PEG 2K monomethyl ether (PEG 2K MME),
100 mM sodium acetate pH 5.1) with a ﬁnal volume of 2 ml,
which was equilibrated against 0.5 ml reservoir solution at
291 K. The initial condition was optimized by the addition of
osmolytes (naturally occurring compounds that affect protein
stability; Bolen & Baskakov, 2001) to favor ordering in the
C-terminal region. The addition of 100 mM sarcosine to the
crystallization condition yielded pyramidal crystals with
dimensions 0.1   0.05   0.05 mm within 3 d. X-ray diffraction
data from D128Valdolase crystals were collected on beamline
X29 at Brookhaven National Laboratory. The crystals were
cryoprotected by passing them through Paratone-N prior to
ﬂash-freezing in a stream of gaseous N2 at 100 K. The
programs DENZO and SCALEPACK (Otwinowski & Minor,
1997) were used to integrate and scale the data to a resolution
of 1.70 A ˚ . D128Valdolase crystallized in space group P21212,
with unit-cell parameters a = 53.32, b= 137.90, c= 50.15 A ˚ .T h e
data-collection statistics are summarized in Table 1.
2.3. Structural solution and refinement
The structure was solved by molecular replacement with the
program AMoRe (Navaza, 1994) using a monomer from the
structure of wild-type human muscle aldolase A (PDB code
1ald; Gamblin et al., 1991) as the initial search model. The
orientation of the monomer obtained by molecular replace-
ment was improved by rigid-body reﬁnement using the Crys-
tallography & NMR System (CNS) program suite (Bru ¨nger et
al., 1998).  A-weighted electron-density maps with coefﬁcients
2Fo   Fc calculated from the model after rigid-body reﬁne-
ment in the program CNS showed good electron density for all
areas of the monomer with the exception of the N-terminal
(1–4) and C-terminal regions (345–363), which failed to
appear even after subsequent rounds of reﬁnement. To mini-
mize model bias in the electron-density maps, the side chain of
residue 128 was modeled as an alanine. The density was clearly
that of a valine in the 2Fo   Fc map and was modeled as such
in subsequent rounds of reﬁnement. Iterative rounds of model
building using Coot (Emsley & Cowtan, 2004) were performed
alternately with rounds of positional, group temperature-
factor and simulated-annealing reﬁnement in the program
CNS. Atest set consisting of 10% of the data was used for Rfree
calculations. In the ﬁnal rounds of reﬁnement water molecules
were included using a 3  cutoff. A total of 655 water molecules
were added to the model as well as six sulfates which were
bound at the surface of the protein. In the ﬁnal round of
reﬁnement, a composite-omit electron-density map was used
to ﬁt the models of DHAP and sulfate to the active site. The
ﬁnal structure had a working R factor of 0.189 and a free R
factor of 0.209. Analysis of the Ramachandran plot deﬁned by
PROCHECK (Laskowski et al., 1993) showed good statistics
for the model, with 91.8% of residues in the most favorable
regions and 8.2% of residues in additionally allowed regions
for D128V aldolase.
2.4. Analytical ultracentrifugation
Puriﬁed D128V aldolase was dialyzed against 0.2 M
ammonium sulfate, 100 mM sodium acetate and 0.1 mM DTT.
The buffer was kept consistent with the crystallization buffer
but with the exclusion of 25% PEG 2K MME, which forms a
highly viscous solution that slows the equilibration process.
Analytical ultracentrifugation (Beckman XLA-90, Beckman
Coulter) was performed to determine the oligomerization
state of D128Valdolase using 0.2, 0.5 and 1 mg ml
 1 aldolase
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Table 1
Crystallographic data-collection and reﬁnement statistics.
Values in parentheses are for the highest resolution shell.
Data-collection statistics
Unit-cell parameters (A ˚ ) a = 53.32, b = 137.90, c = 51.15
Space group P21212
Wavelength (A ˚ ) 1.10
Resolution range (A ˚ ) 100–1.70
Total reﬂections 267879 (24004)
Total unique reﬂections 42325 (4185)
Completeness (%) 99.0 (100.0)
I/ (I) 44.4 (7.3)
Rmerge† 0.09 (0.4)
Redundancy 6.3 (5.7)
Reﬁnement statistics
No. of protein atoms per ASU 3029
No. of reﬂections (working set/free set) 40471/4071
Rwork‡/Rfree§ (%) 0.189/0.209
Average B factors (A ˚ 2)
Overall 15.8
Main-chain atoms 14.6
Side-chain atoms 15.6
DHAP 26.6
Active-site sulfate 45.1
Surface sulfate 65.9
Acetate 47.0
Water 31.2
R.m.s. deviation from ideal
Bond lengths (A ˚ ) 0.004
Angles ( ) 1.3
Dihedrals ( ) 21.5
Impropers ( ) 0.92
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ, where hI(hkl)i is the mean
intensity of the multiple Ii(hkl) observations of symmetry-related reﬂections. ‡ Rwork = P
hkl jFobs   Fcalcj=
P
hkl jFobsj.§ Rfree =
P
hkl2T jFobs   Fcalcj=
P
hkl jFobsj, where the test
set T includes 10% of the data.at 6400, 8000 and 12 000 rev min
 1 at 291 K. The equilibrium
state was veriﬁed at each speed and protein concentration was
monitored at 280 nm. A two-compartment pharmacokinetic
model was ﬁtted to individual data by means of the program
WINNONLIN v.2.1 (Metzler, 1989).
2.5. Analysis of domain movement
The change in intersubunit orientation of the dimer in
comparison to the tetramer was measured using the program
DynDom (Hayward et al., 1997). The buried surface area
between monomers was calculated for the
structures of aldolase (PDB code 1ado) and
D128V aldolase using CNS with a probe
radius of 1.4 A ˚ (Lee & Richards, 1971).
3. Results
3.1. Overall structure
The asymmetric unit contained a single
monomer of D128V aldolase, with residues
5–344 of the subunit modeled into electron
density. The structure was reﬁned to a
resolution of 1.7 A ˚ with a ﬁnal R factor of
18.9% and an Rfree of 21.0%. The ﬁrst four
N-terminal residues and the 19 C-terminal
residues (345–363) were disordered with no
observable electron density, which is
consistent with previously reported crystal
structures (Sygusch et al., 1987; Choi et al.,
1999). Crystallographic data-collection and reﬁnement statis-
tics are reported in Table 1. The structure of the monomer is
not signiﬁcantly different from that of wild-type aldolase, with
an r.m.s. deviation of 0.50 A ˚ . The density at the site of
substitution was well accounted for, reﬂecting a change in the
side chain with no molecular disorder in the region (Fig. 2).
3.2. Crystal-packing analysis
The crystallographic asymmetric unit of the aldolase
structure contained one monomer. Upon building the
symmetry mates, the monomer formed a tightly packed dimer
with its counterpart in the neighboring asymmetric unit.
However, there were no counterparts of this symmetry dimer
to form the native tetramer. Thus, the structure demonstrated
a dimeric oligomerization state. The structural differences
between the D128Valdolase dimer and the wild-type tetramer
(PDB code 1ado) were not signiﬁcant. An overlay of the main-
chain C
  atoms of the dimer with those of the wild-type
aldolase A dimer (subunits B and C) gave an overall r.m.s.
deviation of 0.81 A ˚ (Fig. 3). The 19 residues in the C-terminal
region (residues 345–363) were not included in the calcula-
tions owing to their lack of ordered structure. The difference
in the relative orientations of the monomers within the D128V
aldolase compared with half of the tetramer was analyzed
using the program DynDom (Hayward et al., 1997). The
conformational difference was measured by overlaying a
single monomer from the D128Valdolase on one monomer of
the aldolase tetramer and measuring the displacement of the
second monomer, yielding a 4.1  rotation at the dimer inter-
face. The result was largely a rigid-body movement of the
monomer with the A interface of the dimer acting as a hinge
axis.
3.3. Analytical ultracentrifugation
Sedimentation-equilibrium analytical ultracentrifugation
was employed to show that D128V aldolase is dimeric under
the same conditions as those used for crystallization for X-ray
research papers
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Figure 2
Stereoview of the site of substitution in D128V aldolase. The residues ﬂanking the site of
substitution are shown with the corresponding 2Fo   Fc electron-density map (blue cages)
contoured at 1 .
Figure 3
Overlay of D128V aldolase (cyan) and wild-type aldolase (yellow). The
C
  traces are oriented as in Fig. 1.crystallography. The data were a good ﬁt to a monodisperse
model with a molecular weight equal to that of the aldolase
dimer, 79 580   350 Da (Fig. 4), which is nearly the same as
the calculated molecular weight of 78 388 Da. The data were
not consistent when a monomer or tetramer was used for
ﬁtting (ﬁt not shown). These data conﬁrm that D128Valdolase
forms a dimer in solution.
3.4. Subunit interface
The native aldolase is a homotetramer with two unique
interfaces described as interface A and interface B (see Fig. 1).
In contrast to the A interface, which is comprised of helix-
packing interactions, the B interface exhibits loop–loop
interactions formed by ten buried hydrogen bonds (Table 2).
At each B interface, six of the hydrogen bonds involve the
carboxylate O atoms of Asp128 interacting with the backbone
amides of three consecutive residues (Gly126, Leu127 and
Asp128) of the neighboring subunit (Fig. 5). The hydrophobic
side chain of valine cannot form hydrogen bonds. Thus,
D128Valdolase retains only the A interface, consistent with a
crystallographic dimer. The loop region ﬂanking the substi-
tuted Asp128 residue shows no major displacement arising
from the loss of these conserved hydrogen bonds.
3.5. Calculation of the buried surface area
Calculation of the buried surface area for the tetramer
(PDB code 1ado) showed extensive interactions between the
monomer interfaces. The dimer interface buries 869 A ˚ 2 of
surface area, while the tetramer buries 3460 A ˚ 2. The buried
surface area of D128V aldolase did not signiﬁcantly differ
from the same dimer interface of the tetramer (851 A ˚ 2). If the
crystal contacts from adjacent dimers were included, a total
value of 2146 A ˚ 2 was obtained. There was a net loss of 1314 A ˚ 2
surface area for the D128V aldolase dimer when compared
with the tetramer. Thus, the crystal contacts do not compen-
sate for the loss in buried surface area of the B interface. It is
curious that D128V aldolase did not pack into the wild-type
tetramer during crystallization. Certainly, there are no steric
constraints to prevent this. In contrast, the dimeric aldolase B
A149P variant (Malay et al., 2002) did form the tetramer in the
crystalline state (Malay et al., 2005).
3.6. Active site
Numerous crystal structures of aldolase A bound to sub-
strates or products have been determined (Blom & Sygusch,
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Table 2
Interactions at interface B.
Monomer A Monomer B Distance (A ˚ )
Gln125 CB Gly129 N 3.0
Gly126 N Asp128 OD1 2.8
Leu127 N Asp128 OD2 3.2
Asp128 N Asp128 OD2 3.1
Asp128 OD1 Gly126 N 2.9
Asp128 OD2 Asp128 N 2.9
Asp128 OD2 Leu127 N 3.2
Gly129 N Gln125 OE1 3.0
Glu165 OE1 Asn168 ND2 3.0
Asn168 ND2 Glu165 OE1 3.0
Figure 4
Sedimentation-equilibrium analytical ultracentrifugation of D128V
aldolase under crystallization conditions. The sedimentation-equilibrium
trace using 20 mM protein at 291 K and 8000 rev min
 1 (monitored by
absorbance at 280 nm) is shown in the lower panel. The solid line depicts
the best ﬁt to the data (open circles) performed as described in x2.4.
Residual errors are presented in the upper panel.
Figure 5
The B interface of wild-type aldolase A. Depiction of the hydrogen bonds
(dashed lines) made with Asp128 at the B interface. The coloring scheme
is identical to that of Fig. 1 for the ribbons, with a ball-and-stick
representation in yellow for one monomer and in orange for the second
monomer.1997; Choi et al., 1999, 2001) and have provided insight into
aldolase substrate recognition and catalysis. The active site of
rabbit muscle aldolase A is located in the center of the barrel
and includes a number of conserved charged residues (Arg42,
Lys107, Lys146, Glu187 and Arg303) that are in close proxi-
mity to the Schiff base-forming Lys229 (Lai et al., 1965). A
molecule of the product DHAP and a sulfate ion were found
liganded to the active site of the dimeric D128V aldolase
(Fig. 6a). The presence of the product was a consequence of
the cleavage of Fru 1,6-P2 (retained from the
puriﬁcation process, which included elution
with substrate). The C1 phosphate was
bound by hydrogen bonds to the "-amino
group of Lys229 and the main-chain N
atoms of Ser271 and Gly272 as is found in
other aldolase–DHAP structures (Blom &
Sygusch, 1997; Choi et al., 2001; St-Jean et
al., 2007). The C2 carbonyl and the C3
hydroxyl make hydrogen bonds to the
Arg303 main-chain N atom and guanidino
group, respectively. The sulfate ion binds to
a site comprised of residues Arg303, Lys41
and Arg42, all of which are known to bind
the C6 phosphate of Fru 1,6-P2 (Choi et al.,
1999; St-Jean et al., 2005). There was some
displacement of residues Lys41, Arg42 and
Arg303 in the D128V aldolase structure
when compared with previously solved
DHAP-liganded structures (Fig. 6b) owing
to their binding interaction with the sulfate
ion.
4. Discussion
Fructose-1,6-bisphosphate aldolase has a
highly conserved tetrameric structure with
an atypical, low dissociation constant (Tolan
et al., 2003). A possible explanation for this
unusual stability is that it may have evolved
as a tether molecule for roles in the cell
other than those as a catalyst. The two
interfaces in the quaternary structure (A
and B) are highly conserved amongst aldo-
lases from varied sources (Beernink &
Tolan, 1994, 1996). The A interface is rela-
tively hydrophobic, while the B interface is
hydrophilic in nature and has buried
hydrogen bonds making loop–loop inter-
actions. It has been shown previously that
substitution at one of these interfaces leads
to the dissociation of aldolase into dimers
(Beernink & Tolan, 1994). Monomers have
been formed by making single mutations at
each of the two interfaces. Both the mono-
meric and dimeric forms are fully active
(Beernink & Tolan, 1996). Dissociation of
the wild-type enzyme can only be accom-
plished under harsh conditions (Hsu & Neet, 1973, 1975;
Lebherz, 1972; Rudolph et al., 1976; Gerschitz et al., 1977;
Engelhard et al., 1976). Remarkably, previous studies of
aldolase unfolding show that in 4 M urea, although most of the
backbone is unfolded, three short segments located at the
subunit interface remain intact, maintaining the protein in a
tetrameric state (Deng & Smith, 1999).
Mutations that lead to inborn errors in metabolism are
often associated with the subunit interfaces. The human
research papers
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Figure 6
Stereoview of the active site of fructose 1,6-bisphosphate. (a) DHAP and a sulfate ion depicted
in ball-and-stick representation along with conserved active-site residues in D128Valdolase. A
1  electron-density map is shown (violet cages). (b) Superposition of the active-site residues of
D128Valdolase in red with DHAP and sulfate ion in yellow and the residues of the wild-type
DHAP-bound structure (Blom & Sygusch, 1997; PDB code 1ado) in green. Hydrogen bonds
are shown in black for D128V aldolase and in green for the wild-type structure.mutations D128G, E206K and G346S are associated with
nonspherocytic hemolytic anemia and myopathy (Kishi et al.,
1987; Kreuder et al., 1996; Esposito et al., 2004). Biochemical
studies on the D128G substitution have shown that the
consequence of substitution at position Asp128 is an active
dimer that is thermolabile. Other substitutions at Asp128
showed that the tetramer–dimer dissociation is shifted further
to the right by the substitution of Asp128 by Val (Beernink &
Tolan, 1994) than by substitution by Gly or Ala.
The structure of D128V aldolase showed that this substi-
tution yielded a stable dimer. There was a negligible pertur-
bation in the tertiary structure of the monomers. Moreover,
the A interface of the dimer was retained and did not differ
signiﬁcantly from that of the tetramer, indicating that the
interactions were strong enough to maintain the stable dimer.
The most compelling evidence was that at 291 K the crystal-
packing forces did not reform the tetramer although signiﬁ-
cant buried surface area was lost. The enzyme was stable
enough to form a dimer in solution as observed via analytical
ultracentrifugation. The strength of this interface is consistent
with a potential role of the quaternary structure of aldolase as
a tether molecule.
Finally, the presence of the product DHAP trapped in the
active site after crystallization with Fru 1,6-P2 was an indica-
tion that the enzyme remains catalytically active in the
absence of its native tetrameric structure. Together, these
results strongly suggest that the quaternary structure of native
aldolase is crucial to the performance of its many other
cellular roles.
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